Nephrol Dial Transplant (2004) 19: 469-473
© ERAEDTA 2004; all rights reserved
Case Report
Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure
1Division of Nephrology, 2Division of Dermatology, 3Division of Nuclear Medicine and 4Division of Pathology, Department of Medicine, University Hospital Leuven, Leuven, Belgium
Correspondence and offprint requests to: P. Evenepoel, MD, PhD, Dienst Nefrologie, Universitair Ziekenhuis Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Email: pieter.evenepoel@uz.kuleuven.ac.be
Keywords: fibrosis; renal failure; skin disorder
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
Nephrogenic fibrosing dermopathy (NFD) is a rare, recently described cutaneous fibrosing disorder that primarily affects patients with a history of renal disease [1]. Since the first report in 2000 by Cowper et al., about 100 cases of NFD have been described worldwide, and clusters have been observed in dialysis units and medical centres in the US, the UK and Switzerland. The disorder is not limited to haemodialysis patients as was suggested by initial observations, but may also occur in patients receiving peritoneal dialysis and in patients suffering from renal insufficiency who never have been dialysed [14,7]. Patients typically develop acute, lumpy, plaque-like indurations involving the extremities, and occasionally the trunk and buttocks. The head is almost always spared. The diffuse skin thickening and hardening may be accompanied or preceded by isolated nodules and, rarely bullae. Pruritus and burning pain are common
| Cases |
|---|
Case 1
Case 2
| Discussion |
|---|
This article has been cited by other articles:
![]() |
M. F. Morris, Y. Zhang, H. Zhang, J. C. Prowda, D. N. Silvers, R. A. Fawwaz, and M. R. Prince Features of Nephrogenic Systemic Fibrosis on Radiology Examinations Am. J. Roentgenol., July 1, 2009; 193(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wertman, , BA, E. Altun, D. R. Martin, D. G. Mitchell, J. R. Leyendecker, R. B. O'Malley, D. J. Parsons, E. R. Fuller III, and R. C. Semelka Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities Radiology, September 1, 2008; 248(3): 799 - 806. [Abstract] [Full Text] [PDF] |
||||

